Triflunordazepam
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by OrganoMetallurgy (talk | contribs) at 18:02, 13 June 2017 (removed Category:Organofluorides; added Category:Trifluoromethyl compounds using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:02, 13 June 2017 by OrganoMetallurgy (talk | contribs) (removed Category:Organofluorides; added Category:Trifluoromethyl compounds using HotCat)
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H11F3N2O |
Molar mass | 304.267 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Triflunordazepam (also known as Ro5-2904)[1] is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also
References
- ^ DE Patent 1136709
- ^ Archives Internationales de Pharmacodynamie et de Thérapie. (1965). Vol 154, p 131.
- ^ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry. 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.